Organon And Co Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Organon And Co inventory turnover ratio, the Organon And Co 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 2.06 in the second quarter 2026, yet the ratio remained below the average, as OGN's market remain challenging.Average inventory processing period, for the Organon And Co in Jun 30 2026 quarter, has decreased to 177 days, compare to 180 days, in the Mar 31 2026 quarter.

Within Healthcare sector 190 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 901 in the first quarter 2026, to 1514.

OGN Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Organon And Co Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

OGN Inventory Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Inventory Growth	-7.08 %	0.81 %	6.43 %	7.59 %	12.98 %
Y / Y Cost of Sales Growth	-1.25 %	0.74 %	10.06 %	13.05 %	7.78 %
Inventory Turnover Ratio (TTM)	2.06	2.03	2.03	2.01	1.99
OGN's Total Ranking	# 1514	# 901	# 977	# 977	#
Average inventory processing period	177	180	179	181	183
Seq. Inventory Growth	-1.6 %	-2.35 %	-5.51 %	2.34 %	6.75 %
Seq. Cost of Sales Growth	5.02 %	-11.62 %	2.82 %	3.47 %	7.14 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 52
Healthcare Sector	# 191
Overall Market	# 1514

Inventory Turnover Ratio Statistics
High	Average	Low
2.63	2.21	1.99
(Dec 31 2021)		(Jun 30 2025)

OGN Company Profile >> Back to OGN Efficiency Comparisons >> Compare OGN Inventory Turnover Ratio to its Competitors

Financial Statements
Organon And Co 's Inventories	$ 1,351 Millions	Visit OGN's Balance sheet
Organon And Co 's Cost of Revenues TTM	$ 2,899 Millions	Visit OGN's Income Statement
What are OGN's Sales?		Visit OGN's Sales by Segment

Other Inventory Turnover Ratios
Organon And Co 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
OGN's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for OGN's Competitors
Inventory Turnover Ratio for OGN's Suppliers
Inventory Turnover Ratio for OGN's Customers

You may also want to know
OGN's Sales Growth Rates	OGN's Pe Price to earnings ratio	OGN's Receivables Turnover Ratio	OGN's Stock Quote
OGN's Net Income Growth Rates	OGN's Ps Price to Sales ratio	OGN's Sales per Employee	OGN's Asset Turnover Ratio
OGN's Net Margin	OGN's Pb Price to Book ratio	OGN's Financial Strength Ratios	OGN's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
Sharps Technology Inc	5.68	$ 2.869 Millions	$ 1 Millions
Transmedics Group Inc	5.59	$ 276.120 Millions	$ 49 Millions
Cg Oncology Inc	5.47	$ 7.609 Millions	$ 1 Millions
Opko Health Inc	5.42	$ 348.206 Millions	$ 64 Millions
Charles River Laboratories International inc	5.39	$ 1,761.363 Millions	$ 327 Millions
Tactile Systems Technology Inc	5.12	$ 81.349 Millions	$ 16 Millions
Integer Holdings Corporation	5.03	$ 1,369.168 Millions	$ 272 Millions
Collegium Pharmaceutical Inc	4.99	$ 293.290 Millions	$ 59 Millions
Harrow Inc	4.93	$ 73.636 Millions	$ 15 Millions
Ufp Technologies Inc	4.93	$ 452.046 Millions	$ 92 Millions
Veracyte Inc	4.84	$ 102.741 Millions	$ 21 Millions
West Pharmaceutical Services Inc	4.72	$ 2,103.100 Millions	$ 445 Millions
Henry Schein Inc	4.68	$ 9,342.000 Millions	$ 1,997 Millions
Guardant Health Inc	4.53	$ 413.947 Millions	$ 91 Millions
Idexx Laboratories Inc	4.44	$ 1,714.440 Millions	$ 386 Millions
Cryoport inc	4.40	$ 98.679 Millions	$ 22 Millions
Envista Holdings Corporation	4.37	$ 1,278.500 Millions	$ 293 Millions
Adc Therapeutics Sa	4.17	$ 5.806 Millions	$ 1 Millions
Scilex Holding Company	4.08	$ 14.867 Millions	$ 4 Millions
Medinotec Inc	4.08	$ 4.736 Millions	$ 1 Millions
Alpha Teknova Inc	4.08	$ 28.288 Millions	$ 7 Millions
3m Company	4.07	$ 15,258.000 Millions	$ 3,754 Millions
Electromed Inc	4.02	$ 14.133 Millions	$ 4 Millions
Novocure Limited	4.02	$ 166.921 Millions	$ 41 Millions
Elite Pharmaceuticals Inc	3.95	$ 78.824 Millions	$ 20 Millions
Lftd Partners Inc	3.89	$ 29.233 Millions	$ 8 Millions
Pmgc Holdings Inc	3.87	$ 1.364 Millions	$ 0 Millions
Sonoma Pharmaceuticals Inc	3.83	$ 13.392 Millions	$ 3 Millions
Intelligent Bio Solutions Inc	3.80	$ 2.165 Millions	$ 1 Millions
Iridex Corp	3.80	$ 32.517 Millions	$ 9 Millions

Date modified: 2026-09-05T07:09:47+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.